Consolidated Statements of Cash Flows (unaudited) - USD ($)	9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (21,485,683)	$ (14,217,294)
Adjustments to reconcile net loss to net cash
Depreciation and amortization	257,115	207,278
Decrease in right-of-use asset	260,832	279,023
Unrealized foreign currency transaction gain	(68,653)	352,121
Stock-based compensation	1,330,502	1,452,338
Change in fair value of liability classified warrants	6,962,562	(3,725,895)
Gain on sale of Vyleesi	(7,798,280)	0
Gain on purchase commitment	0	(1,027,322)
Changes in operating assets and liabilities:
Accounts receivable	2,915,760	80,910
Prepaid expenses and other assets	1,206,564	(345,044)
Inventories	(1,154,355)	314,438
Accounts payable	(860,280)	(407,673)
Accrued expenses	(4,171,297)	(1,339,183)
Operating lease liabilities	(264,875)	(278,863)
Other liabilities	(2,118,897)	(1,010,416)
Net cash used in operating activities	(24,988,985)	(19,665,582)
CASH FLOWS FROM INVESTING ACTIVITIES:
Maturity of marketable securities	2,992,890	0
Proceeds from sale of Vyleesi	9,500,000	0
Purchases of property and equipment	(37,615)	(381,531)
Net cash provided by (used in) investing activities	12,455,275	(381,531)
CASH FLOWS FROM FINANCING ACTIVITIES:
stock units	(56,401)	(146,062)
Proceeds from the sale of common stock and warrants,	14,693,779	9,961,462
Payment of finance lease obligations	(79,265)	(75,189)
Proceeds from exercise of warrants	103	78
Net cash provided by financing activities	14,558,216	9,740,289
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	2,024,506	(10,306,824)
CASH AND CASH EQUIVALENTS, beginning of period	7,989,582	29,939,154
CASH AND CASH EQUIVALENTS, end of period	10,014,088	19,632,330
SUPPLEMENTAL CASH FLOW INFORMATION:
Cash paid for interest	13,741	18,523
Conversion of liability classified warrants	11,423,203	0
Conversion of liability classified warrants upon warrant exercise	$ 2,389,903	$ 0